Quick Answer
Coya Therapeutics, Inc. reported Total Assets of $49.95 million for fiscal year 2025.
Coya Therapeutics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $49.95M | +12.6% |
| 2024 | $44.35M | +7.5% |
| 2023 | $41.26M | +391.5% |
| 2022 | $8.40M | +75.2% |
| 2021 | $4.79M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $32.04M | -9.9% | -4.2% |
| June 30, 2025 | $33.45M | -16.2% | -12.9% |
| March 31, 2025 | $38.40M | +2.7% | -13.4% |
| December 31, 2024 | $44.35M | +7.5% | +24.7% |
| September 30, 2024 | $35.55M | +198.9% | -11.0% |
| June 30, 2024 | $39.94M | +176.0% | +6.8% |
| March 31, 2024 | $37.39M | +114.7% | -9.4% |
| December 31, 2023 | $41.26M | +391.5% | +246.9% |
- Coya Therapeutics, Inc. showed an increase of +12.6% in Total Assets compared to the prior fiscal year.
- Over the 2021–2025 period, Coya Therapeutics, Inc.’s total assets has grown by 942.3% (from $4.79 million to $49.95 million).
- The most recent figure is from Coya Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 16, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: